We verified the combined effect in LMP1-expressing B cell lymphoma cells and found that combined treatment with doxorubicin and TCP enhanced the level of apoptosis in LMP1-expressing cells beyond that seen for either mono-treatment. The gene discussed is PDLIM7; the disease is B-cell non-Hodgkin lymphoma.